As regulators, prosecutors, and lawmakers continue their scrutiny of stock option backdating, a new study may offer investors more ammunition as they ramp up legal complaints against companies implicated in the much-maligned practice.
A study by researchers at the University of Michigan concludes that backdating is costing shareholders big bucks for what amounts to relatively paltry gains for executives who receive backdated option grants.
